Gland Pharma Q2 Results
- BSE: 543245
- NSE: GLAND
- ISIN: INE068V01023
- Sector: Biotechnology & Drugs
BSE
1,785
28.45 (1.62%)
28.45 (1.62%)Volume4.99 K
Updated: Mon 25 Nov, 2024 | 15:29:46
NSE
1,773.9518.90 (1.08%)
18.90 (1.08%)Volume1.73 L
Updated: Mon 25 Nov, 2024 | 15:40:43
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,405.83 Cr.(0.29%)
- Operating Profit₹203.23 Cr.(17.86%)
- Profit After Tax₹163.53 Cr.(13.75%)
- Operating Margin14.46%(-18.22%)
Note: Comparison is on YoY basis
Quarterly - Gland Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,405.83 | 1,208.69 | -% | 1,373.42 | -% |
| Selling/ General/ Admin Expenses Total | 375.19 | 304.80 | -% | 363.23 | -% |
| Depreciation/ Amortization | 93.83 | 65.31 | -% | 81.30 | -% |
| Other Operating Expenses Total | 158.13 | 157.04 | -% | 164.55 | -% |
| Total Operating Expense | 1,202.60 | 980.05 | -% | 1,130.64 | -% |
| Operating Income | 203.23 | 228.64 | -% | 242.78 | -% |
| Net Income Before Taxes | 256.78 | 261.27 | -% | 289.89 | -% |
| Net Income | 163.53 | 194.10 | -% | 194.08 | -% |
| Diluted Normalized EPS | 9.93 | 11.78 | -% | 11.78 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST